Key Facts

Invested since 2019
Based in Brandenburg

About the company

Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.

Do you want to

know more about this company?

Zum Artikel

Dr. Anke Caßing Principal

Dr. Anke CaßingPrincipal

Pantherna Therapeutics in the news

Pantherna Logo Zum Artikel

News

11. January 2022

Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs   

Zum Artikel

News

3. July 2019

“First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment

More startups from Life Sciences